In its recent recall of all antacids that contain ranitidine, the U.S. Food and Drug Administration is requesting all manufacturers of popular heartburn medications, such as Zantac and ranitidine manufacturers, to withdraw all prescription and over-the-counter products containing ranitidine from the market immediately.
The recall came after tests finding harmful levels of a compound called N- nitrosodimethylamine (NDMA) present in the medicines, classifies as a probable human carcinogen, according to the World Health Organization (WHO) and the Environmental Protection Agency (EPA).
The testing process revealed that ranitidine reacts over time during storage and when exposed to elevated temperatures that occur during transportation or when stored in the home. When ranitidine reacts, it produces harmful levels of NDMA and becomes a potential health risk for consumers. If present in high enough concentrations, the compound could cause cancer.
Consumers of antacids that contain ranitidine, such as Zantac and ranitidine, who developed cancer could be entitled to compensation.
FDA Recalls Antacids Containing Dangerous Levels of NDMA
Ranitidine-based drugs, available in prescription and over-the-counter variants, serve as medications for heartburn, ulcers of the stomach and intestines, acid reflux, and other related health conditions.
Innumerable prescriptions and other over-the-counter (OTC) purchases occurred for consumers wishing to treat problems arising from the acid produced in the stomach.
After tests have found ranitidine to be harmful to people, and the potential cause of certain cancers, the following antacids have been recalled by the FDA:
- Gemini Laboratories – Nizatidine Oral Solution, 15 mg/mL
- American Health Packaging – Ranitidine Tablets, USP 150mg
- Mylan – Nizatidine Capsules, 150mg, and 300mg
- Northwind – Ranitidine Tablets, 150mg, and 300mg
- ani – Ranitidine Tablets, 150mg, and 300mg
- Glenmark – Ranitidine Tablets, 150mg, and 300mg
- Amneal – Ranitidine Tablets, 150mg, and 300mg
- PrecisionDose – Ranitidine Oral Solution, USP 150mg/10mL
- GSMS Incorporated – Ranitidine HCI, 150mg and 300mg Capsules
- AHP – Ranitidine Liquid Unit Dose Cups
- Aurobindo & DG Health – Ranitidine
- Novitium Pharma – Ranitidine Hydrochloride Capsules 150mg and 300mg
- Lannett Company, Inc. – Ranitidine Syrup (Ranitidine Oral Solution, USP) 15mg
- Dr. Reddy’s Kroger – Ranitidine Tablets & Capsules
- Walgreens – Ranitidine Tablets & Capsules
- Sanofi – Zantac 150, Zantac 150 Cool Mint, Zantac 75 (OTC products)
- Perrigo Company – Ranitidine (all pack sizes)
- Apotex Corp. – Ranitidine Tablets, 75mg and 150mg
- Sandoz Inc. – Ranitidine Hydrochloride Capsules
- Camber Pharmaceuticals Inc. – Valsartan Tablets, USP, 40mg, 80mg, 160mg, and 320mg
- Major Pharmaceuticals – Valsartan Tablets, 80mg USP and 160mg USP
- Prinston Pharmaceutical Inc. – Valsartan Tablets, Valsartan-Hydrochloride Tablets
Following the FDA’s recent recall of antacids such as Zantac, lawyers represent clients filing ranitidine lawsuits list stomach, liver, and bladder cancers amongst the primary injuries associated with NDMA. Furthermore, some claim manufactures of ranitidine drugs knew about the dangers of NDMA, yet concealed the risks of the drugs’ toxic side effects from the American public.
Latest Advice for People Who Use Ranitidine Medications From the FDA
Current advice from the FDA for daily users of OTC antacids containing ranitidine is to stop using them and to dispose of them safely, in line with FDA drug disposal guidelines. Patients prescribed ranitidine are prompted to discuss alternative treatment options with their chosen healthcare professional or doctor. Pregnant mothers are also advised to discontinue using the treatments since unborn babies can suffer exposure to NDMA in the womb, according to Placenta, a medical journal.
If you are experiencing any unusual symptoms such as unexplained weight loss, lack of appetite, blood in stools or vomit or abdominal pain, it is best to check with your doctor to rule things out, for peace of mind.
Contact Pintas & Mullins Law Firm for Help
If you are suffering or have tragically lost a loved one to cancer and believe exposure to NDMA found in antacid products such as Zantac or other ranitidine medications could be the cause, you may be entitled to pursue compensation. Potential compensation may help with costs towards:
- Current and future medical bills
- Rehabilitation costs
- Pain, suffering, and inconvenience
- Lost wages
- Loss of future earnings
- Burial and funeral costs in the tragic event of wrongful death
Through responsive, compassionate service and advocacy, the team at Pintas & Mullis Law Firm is committed to providing medical drug litigation for their clients whose lives have been adversely affected by dangerous prescription and OTC drugs.
If you would like further information on what our firm can do for you, speak to us today at (800) 635-1144 for a free ranitidine lawsuit case review. Additionally, we offer a contingency fee service, meaning there are no upfront costs to you should you qualify to pursue compensation.